Skip to content

Effectiveness of complementary and alternative approaches to lifestyle diseases: a summary of systematic reviews

Effectiveness of complementary and alternative approaches to lifestyle diseases: a summary of systematic reviews - Effectiveness of complementary and alternative approaches to lifestyle diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000018827
Enrollment
Unknown
Registered
2015-08-27
Start date
2018-02-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lifestyle diseases

Interventions

None listed

Sponsors

Tokyo University of Agriculture
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Studies will be eligible if they are SRs based on all types of complementary and alternative approaches (i.e., interventions) to lifestyle diseases. This study will be a review based on SRs and will be restricted to original SRs of adult patients with six types of lifestyle diseases: hypertension, hyperlipidemia, type 2 diabetes, colon cancer, stroke, and obesity.

Exclusion criteria

Exclusion criteria: Not SR (i.e., narrative reviews)

Design outcomes

Primary

MeasureTime frame
Our main goal is to summarize the specific effectiveness of an intervention for each section of the ICD-10 or ICD-11. In addition, we will create an evidence frame work together with age and sex while we examine the validity and interpretation of each SR's result. We are also interested in the accuracy of the implementation and description of each SR. We will evaluate each claim report by the AMSTAR checklist (Shea BJ, et al., 2007).

Secondary

MeasureTime frame
We will not define the secondary outcomes.

Countries

Japan

Contacts

Public ContactHiroharu Kamioka

Tokyo University of Agriculture Faculty of Regional Environment Science

h1kamiok@nodai.ac.jp03-5477-2587

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026